Stereotactic Ablative Radiotherapy (SABR) in Early Stage Non-Small Cell Lung Cancer: Comparing Survival Outcomes in Adenocarcinoma and Squamous Cell Carcinoma

With an incidence of approximately 190,000 annual cases in the United States, non-small cell lung cancer (NSCLC) is the most common primary lung cancer [1]. NSCLC is a heterogeneous disease, with important genetic, molecular, and histological differences that can provide clinicians with both prognostic and predictive information. From a histologic standpoint, NSCLC consists of two principal groupings: adenocarcinoma (ADC) and squamous cell carcinoma (SCC).

Source: Lung Cancer - December 24, 2018 Category: Cancer & Oncology Authors: Stephen Abel, Shaakir Hasan, Richard White, Lana Schumacher, Gene Finley, Athanasios Colonias, Rodney E. Wegner Source Type: research